Muto M - Search Results

1

First-Line Genomic Profiling in Previously Untreated Advanced Solid Tumors for Identification of Targeted Therapy Opportunities.

Matsubara J, Mukai K, Kondo T, Yoshioka M, Kage H, Oda K, Kudo R, Ikeda S, Ebi H, Muro K, Hayashi R, Tokudome N, Yamamoto N, Muto M. Matsubara J, et al. Among authors: muto m. JAMA Netw Open. 2023 Jul 3;6(7):e2323336. doi: 10.1001/jamanetworkopen.2023.23336. JAMA Netw Open. 2023. PMID: 37459099 Free PMC article.

2

Exceptional Response of Pancreatic Acinar Cell Carcinoma and Bile Duct Cancer to Platinum-Based Chemotherapy in a Family With a Germline BRCA2 Variant.

Sunami T, Yamada A, Kondo T, Kanai M, Nagai K, Uchida Y, Yokode M, Matsumori T, Uza N, Murakami H, Yamada T, Muto M. Sunami T, et al. Among authors: muto m. Pancreas. 2022 Oct 1;51(9):1258-1262. doi: 10.1097/MPA.0000000000002150. Pancreas. 2022. PMID: 37078954

3

SMARCA4-Deficient Poorly Differentiated Adenocarcinoma of the Gallbladder.

Koyasu S, Sugimoto A, Matsubara J, Muto M, Nakamoto Y. Koyasu S, et al. Among authors: muto m. Clin Nucl Med. 2024 Jul 1;49(7):688-689. doi: 10.1097/RLU.0000000000005217. Epub 2024 Apr 8. Clin Nucl Med. 2024. PMID: 38598517

4

Nationwide survey of the secondary findings in cancer genomic profiling: survey including liquid biopsy.

Shimada S, Yamada T, Minamoto A, Matsukawa M, Yabe I, Tada H, Oda K, Ueki A, Higashigawa S, Morikawa M, Sato Y, Hirasawa A, Ogawa M, Kondo T, Yoshioka M, Kanai M, Muto M, Kosugi S. Shimada S, et al. Among authors: muto m. J Hum Genet. 2025 Jan;70(1):33-40. doi: 10.1038/s10038-024-01294-x. Epub 2024 Sep 17. J Hum Genet. 2025. PMID: 39289525

5

Analysis of particle therapy registries based on a unified treatment policy for esophageal cancer.

Tokumaru S, Ishikawa H, Soejima T, Kimoto T, Takakusagi Y, Tamamura H, Wada H, Taguchi H, Uchinami Y, Hiroshima Y, Hojo H, Kamei T, Muto M, Igeta M. Tokumaru S, et al. Among authors: muto m. J Radiat Res. 2023 Jun 16;64(Supplement_1):i16-i24. doi: 10.1093/jrr/rrad012. J Radiat Res. 2023. PMID: 37036770 Free PMC article.

6

Nationwide Validation Study of the Prognostic Significance of Stratification Using Pathological Stage and Response to Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.

Matsuda S, Kitagawa Y, Okui J, Okamura A, Kawakubo H, Takemura R, Muto M, Kakeji Y, Takeuchi H, Watanabe M, Doki Y. Matsuda S, et al. Among authors: muto m. Ann Surg. 2023 Aug 1;278(2):e234-e239. doi: 10.1097/SLA.0000000000005701. Epub 2022 Oct 29. Ann Surg. 2023. PMID: 36538635

7

Nivolumab for malignant transformation of ovarian mature cystic teratoma.

Yoshimura K, Yamanoi K, Kanai M, Okunomiya A, Sagae Y, Sunada M, Taki M, Ukita M, Chigusa Y, Horie A, Yamaguchi K, Hamanishi J, Minamiguchi S, Yamamoto N, Muto M, Mandai M. Yoshimura K, et al. Among authors: muto m. Gynecol Oncol Rep. 2022 Dec 10;44:101115. doi: 10.1016/j.gore.2022.101115. eCollection 2022 Dec. Gynecol Oncol Rep. 2022. PMID: 36560959 Free PMC article.

8

Effect of Severe Renal Dysfunction on the Plasma Levels of DNA-Reactive Platinum after Oxaliplatin Administration.

Nakagawa S, Shimazaki A, Funakoshi T, Yonezawa A, Kataoka S, Horimatsu T, Hira D, Itohara K, Imai S, Nakagawa T, Matsubara T, Yanagita M, Muto M, Matsubara K, Terada T. Nakagawa S, et al. Among authors: muto m. Biol Pharm Bull. 2023;46(2):194-200. doi: 10.1248/bpb.b22-00578. Biol Pharm Bull. 2023. PMID: 36724948 Free article.

9

Risk factors for the development of second primary esophageal squamous-cell carcinoma after endoscopic resection for esophageal squamous-cell carcinoma according to genetic polymorphisms related to alcohol and nicotine metabolism.

Katada C, Yokoyama T, Mure K, Doyama H, Nakanishi H, Shimizu Y, Yamamoto K, Furue Y, Tamaoki M, Koike T, Kawahara Y, Kiyokawa H, Konno M, Yokoyama A, Ohashi S, Ishikawa H, Yokoyama A, Muto M. Katada C, et al. Among authors: muto m. Jpn J Clin Oncol. 2023 Aug 30;53(9):774-780. doi: 10.1093/jjco/hyad070. Jpn J Clin Oncol. 2023. PMID: 37370215

10

Development of a novel COMPAssion focused online psyChoTherapy for bereaved informal caregivers: the COMPACT feasibility trial protocol.

Uneno Y, Kotera Y, Fujisawa D, Kataoka Y, Kosugi K, Murata N, Kessoku T, Ozaki A, Miyatake H, Muto M. Uneno Y, et al. Among authors: muto m. BMJ Open. 2022 Dec 22;12(12):e067187. doi: 10.1136/bmjopen-2022-067187. BMJ Open. 2022. PMID: 36549732 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,490 results

Search Page

Filters